OM
Opaleye Management Inc. bought $30K of GRCE stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 14,632 shares of GRCE stock worth $30K, per an SEC Form 4 filed Oct 13, 2026.
It was an open-market purchase.
The trade happened on Oct 8, 2026, 5 days before it was made public.
GRCE has moved -12.7% since the trade date, from $2.04 to $1.78 (Nov 5, 2026 close).
- Traded
- Oct 8, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 5 days
- Price since
- -12.7%
- Role
- 10% owner
- Source
- SEC Form 4